PubRank

Her2 and TGFBeta CTLs in Treatment of Her2 Positive Malignancy (HERCREEM)

Clinical Trial ID NCT00889954

PubWeight™ 23.94‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00889954

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Targeting the TGFβ signalling pathway in disease. Nat Rev Drug Discov 2012 4.30
2 Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor. Blood 2010 3.57
3 Adoptive immunotherapy for cancer or viruses. Annu Rev Immunol 2014 1.61
4 Potential targets for pancreatic cancer immunotherapeutics. Immunotherapy 2011 1.29
5 CAR T cells for solid tumors: armed and ready to go? Cancer J 2014 1.29
6 Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors. Cancer Discov 2015 1.18
7 Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T Cells. Front Immunol 2013 0.98
8 Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy. Clin Cancer Res 2016 0.95
9 Adoptive cell therapies for glioblastoma. Front Oncol 2013 0.90
10 The Evolution of T-cell Therapies for Solid Malignancies. Clin Cancer Res 2015 0.84
11 Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cells. ISRN Oncol 2012 0.84
12 Gene therapy for lung neoplasms. Clin Chest Med 2011 0.84
13 Genetically engineered T cells for the treatment of cancer. J Intern Med 2013 0.83
14 Immunotherapy of Childhood Sarcomas. Front Oncol 2015 0.81
15 Targeting CD8+ T-cell tolerance for cancer immunotherapy. Immunotherapy 2014 0.81
16 Immunotherapy in pediatric malignancies: current status and future perspectives. Future Oncol 2014 0.78
17 Dysregulation of TGFβ1 Activity in Cancer and Its Influence on the Quality of Anti-Tumor Immunity. J Clin Med 2016 0.77
18 Cellular immunotherapy for pediatric solid tumors. Cytotherapy 2014 0.77
19 New Strategies for the Treatment of Solid Tumors with CAR-T Cells. Int J Biol Sci 2016 0.77
20 Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology. Pediatr Blood Cancer 2015 0.75
Next 100